Preliminary Report on Phase 1 Clinical Experience with Combined cis-diamminedichloride Platinum (II) (PDD) and 5-FU
- 1 January 1974
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Inhibition of Growth or Cell Division in Escherichia coli by Different Ionic Species of Platinum(IV) ComplexesPublished by Elsevier ,2021
- Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)Cancer, 1972
- The interaction of platinum II compounds with bacteriophages T7 and R17Chemico-Biological Interactions, 1972
- Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum CompoundsNature, 1972
- Antileukaemic and Nephrotoxic Properties of Platinum CompoundsNature, 1971
- Cis-Dichlorodiammineplatinum [II]: Inhibition of Nucleic Acid Synthesis in Lymphocytes Stimulated with PhytohemagglutininExperimental Biology and Medicine, 1971
- CIS-dichlorodiammineplatinum (II)Biochemical Pharmacology, 1970
- Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitroInternational Journal of Cancer, 1970
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965